SkyePharma AG   Report issue

For profit Phase 1 Phase 3
Founded: Saint-Quentin-Fallavier France (1983)
Status: No NME R&D (1983)

Organization Overview

First Clinical Trial
2004
NCT00830102
First Marketed Drug
1999
isosorbide (isordil)
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Skye Biologics | SKYEPHARMA AG